Lmito Therapeutics
PrivateLast Round
Series A
Aug 31, 2020
Total Funding Raised
$5.89M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Lmito Therapeutics operates in Healthcare & Life Sciences and is based in South Korea. Its latest recorded funding round was a Series A round in August 2020.
Lmito Therapeutics is a clinical-stage pharmaceutical company that develops novel therapies for autoinflammatory, autoimmune, and fibrotic diseases through metabolic reprogramming.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lmito Therapeutics Comparables
Compare Lmito Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sitryx | 85% | |
| Capacity Bio | 78% | |
| Innovo Therapeutics | 78% |
For institutional investors. Book with your work email.
Lmito Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lmito Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dt& Investment | Series A |
| Yuanta Investment | Series A |
| Kiwoom Investment | Series A |
| Stonebridge Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 346% MoM, from 290 to 1.3K.
- Jan 22, 2026
Monthly visitors grew 98% MoM, reaching 3.6K.
For institutional investors. Book with your work email.
Lmito Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lmito Therapeutics's valuation, stock price, and market status.
Is Lmito Therapeutics a public or private company?
Lmito Therapeutics is a private company.
What is the current stock price of Lmito Therapeutics?
Lmito Therapeutics is a private company, so its shares have no public market price. Caplight tracks Lmito Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lmito Therapeutics worth (valuation)?
Valuation information for Lmito Therapeutics is not publicly available.
Can I buy Lmito Therapeutics stock?
Lmito Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lmito Therapeutics's last funding round?
Lmito Therapeutics's most recent funding round was Series A on August 31, 2020.
Who are the main investors in Lmito Therapeutics?
Key investors in Lmito Therapeutics include Dt& Investment, Yuanta Investment, Kiwoom Investment, Stonebridge Ventures.
Will Lmito Therapeutics IPO soon?
No public IPO plans have been announced for Lmito Therapeutics.
How can I track Lmito Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Lmito Therapeutics's shares on secondary markets.